CA2449189A1 - Modulateurs allosteriques positifs des recepteurs ampa naphtothiazine (paarm) - Google Patents

Modulateurs allosteriques positifs des recepteurs ampa naphtothiazine (paarm) Download PDF

Info

Publication number
CA2449189A1
CA2449189A1 CA002449189A CA2449189A CA2449189A1 CA 2449189 A1 CA2449189 A1 CA 2449189A1 CA 002449189 A CA002449189 A CA 002449189A CA 2449189 A CA2449189 A CA 2449189A CA 2449189 A1 CA2449189 A1 CA 2449189A1
Authority
CA
Canada
Prior art keywords
alkyl
nr6r7
different
halogen
halogen atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002449189A
Other languages
English (en)
Inventor
Angelo Ceci
Klaus Klinder
Thomas Weiser
Karin Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2449189A1 publication Critical patent/CA2449189A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

La présente invention concerne de nouveaux modulateurs allostériques positifs des récepteurs AMPA de formule générale (I), dans laquelle R?1¿, R?2¿, R?3¿, R?4¿ et R?5¿ ont les significations indiquées dans la description et dans les revendications, ainsi que des méthodes de préparation desdits modulateurs et leur utilisation sous forme de compositions pharmaceutiques.
CA002449189A 2001-05-17 2002-05-15 Modulateurs allosteriques positifs des recepteurs ampa naphtothiazine (paarm) Abandoned CA2449189A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10123952.1 2001-05-17
PCT/EP2002/005338 WO2002100411A1 (fr) 2001-05-17 2002-05-15 Modulateurs allosteriques positifs des recepteurs ampa naphtothiazine (paarm)

Publications (1)

Publication Number Publication Date
CA2449189A1 true CA2449189A1 (fr) 2002-12-19

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002449189A Abandoned CA2449189A1 (fr) 2001-05-17 2002-05-15 Modulateurs allosteriques positifs des recepteurs ampa naphtothiazine (paarm)

Country Status (26)

Country Link
EP (1) EP1404340A1 (fr)
JP (1) JP2004529980A (fr)
KR (1) KR20040007572A (fr)
CN (1) CN1533278A (fr)
AR (1) AR036332A1 (fr)
BG (1) BG108324A (fr)
BR (1) BR0209796A (fr)
CA (1) CA2449189A1 (fr)
CO (1) CO5550460A2 (fr)
CZ (1) CZ20033112A3 (fr)
DE (1) DE10123952A1 (fr)
EA (1) EA006608B1 (fr)
EC (1) ECSP034852A (fr)
EE (1) EE200300566A (fr)
HR (1) HRP20030933A2 (fr)
HU (1) HUP0401273A3 (fr)
IL (1) IL158642A0 (fr)
MX (1) MXPA03010373A (fr)
NO (1) NO20035088L (fr)
NZ (1) NZ530154A (fr)
PL (1) PL364053A1 (fr)
SK (1) SK14222003A3 (fr)
UY (1) UY27290A1 (fr)
WO (1) WO2002100411A1 (fr)
YU (1) YU90403A (fr)
ZA (1) ZA200308466B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090047534A (ko) * 2006-08-31 2009-05-12 더 거버너스 오브 더 유니버시티 오브 앨버타 양성 알로스테릭 ampa 수용체 조절인자를 사용하여 호흡 저하를 억제하는 방법
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
JP2002518498A (ja) * 1998-06-25 2002-06-25 メルク エンド カムパニー インコーポレーテッド ナフト[1,8−de]チアジン−2−イルメチルカルバペネム抗菌物質
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CN1533278A (zh) 2004-09-29
SK14222003A3 (sk) 2004-05-04
AR036332A1 (es) 2004-09-01
NZ530154A (en) 2005-09-30
ZA200308466B (en) 2004-05-24
MXPA03010373A (es) 2004-03-16
CZ20033112A3 (en) 2004-03-17
CO5550460A2 (es) 2005-08-31
BG108324A (bg) 2004-12-30
HUP0401273A2 (hu) 2004-10-28
IL158642A0 (en) 2004-05-12
KR20040007572A (ko) 2004-01-24
HRP20030933A2 (en) 2004-04-30
ECSP034852A (es) 2003-12-24
PL364053A1 (en) 2004-12-13
JP2004529980A (ja) 2004-09-30
NO20035088D0 (no) 2003-11-14
NO20035088L (no) 2003-11-14
UY27290A1 (es) 2002-12-31
EA200301167A1 (ru) 2004-06-24
BR0209796A (pt) 2004-06-01
EP1404340A1 (fr) 2004-04-07
DE10123952A1 (de) 2002-11-21
EE200300566A (et) 2004-02-16
WO2002100411A1 (fr) 2002-12-19
HUP0401273A3 (en) 2006-11-28
EA006608B1 (ru) 2006-02-24
YU90403A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
KR20080098443A (ko) 세라마이드 키나제 조절
WO2007049532A1 (fr) Derive aminodihydrothiazine
EP0352613A2 (fr) Aminométhyl-tétralines substituées et leurs analogues hétérocycliques
NO323400B1 (no) Polycykliske dihydrotiazol-forbindelser og farmasoytiske preparater inneholdende slike, deres fremstilling og anvendelse for profylakse eller behandling av fedme og type II diabetes.
US20030199502A1 (en) Indoloquinazolinones
CA2399377C (fr) Nouveaux modulateurs (paarm) allosteriques positifs de recepteurs ampa, leur methode de production et leur utilisation comme medicaments
JP2002525373A (ja) 2−ピペラジノアルキルアミノベンゾアゾール誘導体:ドーパミン受容体サブタイプ特殊リガンド
CA2449189A1 (fr) Modulateurs allosteriques positifs des recepteurs ampa naphtothiazine (paarm)
US7026475B2 (en) Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions
US6602865B1 (en) Pyridazino(4,5-b)(1,5)oxazepinone, -thiazepinone and -diazepinone compounds
AU2002345759A1 (en) Naphtothiazine positive allosteric AMPA receptor modulators (PAARM)
EP1851209A2 (fr) Derives de [1,2,4]-dithiazoli(di)ne, inducteurs de la gluthathione-s-transferase et de la nadph quinone oxydoreductase, destines a la prophylaxie et au traitement d'etats nocifs associes a la cytotoxicite en general et, plus particulierement, a l'apoptose
JP2005519117A (ja) キノリン誘導体
AU762526B2 (en) Novel type condensed pyridazinone compounds
JP2967231B2 (ja) 1,4―チアジン誘導体
KR19990021835A (ko) 축합 벤조디아제피논 유도체 및 이의 의약 조성물
US6288093B1 (en) Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments
FR2710062A1 (fr) Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
EP3423053A1 (fr) Utilisation de dérivés de 2-oxo-2h-pyrrol-l(5h)-carboxamide en tant qu'agents anti-vih et procédé de production associé
NZ723972A (en) Hepatitis b core protein allosteric modulators
JP2002519346A (ja) 1−(ベンゾチアゾール−2−イル)−4−(1−フェニルメチル)ピペラジン:ドーパミン受容体サブタイプ特異リガンド
MXPA01007493A (en) Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments

Legal Events

Date Code Title Description
FZDE Discontinued